Flonida Cream

📦 Elke bestelling is gedekt door onze Reshipment Assurance Policy — als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.

Waarom bestellen bij MedsBase

Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen — geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor — nooit “MedsBase” of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.

What Is Flonida Cream?

Flonida Cream is a topical fluorouracil (5-FU) 5% w/w cream from Yash Pharma, supplied in a 10 g tube. Fluorouracil is a pyrimidine antimetabolite chemotherapy drug first synthesised in 1957 and widely used as an intravenous cytotoxic for gastrointestinal, breast and head-and-neck cancers. The topical formulation was introduced in the 1960s after the observation that IV 5-FU cleared actinic keratoses on sun-exposed skin. Internationally branded as Efudix (UK, EU), Efudex (US), Adrucil (IV form), Carac, Tolak, Fluoroplex, and generics. It remains the most-used topical chemotherapy for field-effect skin cancer and pre-cancer.

How Does Flonida Cream Work?

• Metabolised to 5-fluorodeoxyuridine monophosphate (FdUMP), which inhibits thymidylate synthase (TS) — the enzyme that converts dUMP to dTMP. Without dTMP, DNA synthesis halts.
• Also incorporates into RNA as FUTP and into DNA as FdUTP, disrupting transcription and triggering apoptosis in rapidly dividing cells.
• Selectively destroys rapidly-proliferating dysplastic and malignant keratinocytes, sparing normal, slowly-dividing keratinocytes. The selectivity is imperfect, which is why normal skin at the treatment site also gets inflamed.
• Minimal systemic absorption from topical application to intact skin (<10% of applied dose), but absorption rises sharply when applied to large surface areas, eroded or ulcerated skin, or occluded under dressings.
• Metabolism: systemic 5-FU is catabolised by dihydropyrimidine dehydrogenase (DPD). Patients with complete or partial DPD deficiency (~3-5% of the population for partial deficiency; ~0.2% complete) cannot clear 5-FU and suffer severe systemic toxicity even from topical application — this is an absolute contraindication.

The expected visible reaction sequence over the course of a 2-6 week treatment: mild redness (week 1) → intense erythema and burning (week 2-3) → erosion, crusting, weeping (week 3-4) → healing and re-epithelialisation (week 4-6) → residual pinker-than-surroundings skin fading over 1-2 months. This sequence is the mechanism of action and is NOT an adverse reaction. Patients often find it alarming; prior education is essential. Stopping early because the skin “looks bad” is the most common reason for treatment failure — the visible reaction signals that the drug is working.

When Flonida Cream Is Used

Licensed indications (under dermatology supervision and after biopsy confirmation where appropriate):

• Actinic keratoses (solar keratoses) — sun-induced pre-cancerous lesions on face, scalp, ears, dorsum of hands, forearms. Topical 5-FU is first-line for field-effect (multiple lesions over a broad area) treatment.
• Superficial basal cell carcinoma (sBCC) — biopsy-confirmed, on the trunk or extremities (not head/neck unless specifically directed), where surgical excision is impractical or cosmetically undesirable.
• Bowen’s disease (squamous cell carcinoma in situ) — biopsy-confirmed, well-defined, on the trunk or extremities.
• Keratoacanthoma (specialist use, specific subtypes only)

Flonida Cream is NOT voor:

• Nodular or invasive basal cell carcinoma — needs surgical excision, Mohs surgery or radiotherapy
• Invasive squamous cell carcinoma — needs surgical excision
• Melanoma or melanoma-suspicious lesions
• Lesions without a histological diagnosis — biopsy must confirm the type of skin cancer first; topical 5-FU can flatten and partially treat an invasive cancer enough to delay surgical diagnosis while deeper disease progresses
• Routine wrinkles, sun damage or pigmentation (cosmetic use) — this is a chemotherapy drug, not a cosmetic
• Intertriginous or mucosal sites

Flonida Cream Dosage and Treatment Protocols

Standard Actinic Keratosis Protocol (Face, Scalp)

1. Wash the treatment area with a mild soap and lukewarm water; pat dry.
2. Apply a thin film of Flonida Cream directly onto the affected area and a short margin (1-2 cm) of surrounding skin; rub in gently with a gloved finger or a cotton bud.
3. Wash hands thoroughly after application. Do NOT touch eyes, lips, inside of nostrils, or mucous membranes with cream-contaminated hands.
4. Apply twice daily for 2-4 weeks on face and scalp. Treatment length is titrated against the clinical reaction — once a good inflammatory/erosive reaction is established, the target has been reached and treatment can be stopped.
5. No occlusive dressings. The cream is left uncovered to air — occlusion increases absorption and the severity of reaction beyond what is intended.
6. After stopping, the skin continues to heal over 2-6 weeks. Apply bland emollient (petroleum jelly, paraffin-based moisturiser) during the healing phase. NO cosmetics, NO sun exposure.

Superficial BCC / Bowen’s Disease Protocol

1. Biopsy must confirm diagnosis first. Superficial BCC on trunk / extremities, or Bowen’s disease, only — under specialist dermatology direction.
2. Apply twice daily for 3-6 weeks.
3. Treatment often looks worse and takes longer than AK treatment — expect intense inflammation, erosion and weeping over 2-3 weeks, then a slow healing phase.
4. Follow-up biopsy at 8-12 weeks is often recommended to confirm clearance. Recurrence rates at 5 years are 10-30% — annual dermatology follow-up for 5 years is standard.

Alternative Schedules

Your dermatologist may recommend a pulse schedule (e.g. 2 weeks on, 2 weeks off, repeat; or weekends-only for extended periods) to reduce severity of the inflammatory reaction in patients who cannot tolerate a standard 4-week course. Combination with calcipotriol (4-day regimen) or sequential imiquimod is used for severe field disease. These protocols belong to specialist dermatology — do not improvise on your own.

Expected Reaction Timeline — What to Expect

Bijwerkingen

• Expected (ALL patients): erythema, burning, stinging, erosion, crusting, weeping, tenderness at the treatment site — these ARE the therapeutic reaction
• Vaak voorkomend: pain, itching, dryness, photosensitivity, local oedema, transient hyper- or hypo-pigmentation
• Minder vaak voorkomend: allergic contact dermatitis, milia formation during healing, residual telangiectasia at treatment site, scarring (usually mild)
• Zeldzaam: Stevens-Johnson syndrome, photo-onycholysis if nails exposed, corneal damage if cream reaches the eye
• Serious (DPD-deficient patients, or large-area exposure): severe mucositis, diarrhoea, bone-marrow suppression, neurotoxicity — systemic 5-FU toxicity can occur even from topical application in DPD-deficient patients and requires hospital management

Contra-indicaties & waarschuwingen

• Pregnancy (Category X) — ABSOLUTE. 5-FU is teratogenic. Women of childbearing potential must use effective contraception during and for at least 3 months after treatment. Pregnancy test before initiation is standard.
• Breastfeeding — ABSOLUTE. Do not breastfeed during treatment.
• Known or suspected DPD (dihydropyrimidine dehydrogenase) deficiency — ABSOLUTE. Patients with family history of unexplained severe reactions to fluoropyrimidines (capecitabine, systemic 5-FU) should be screened before topical 5-FU.
• Known hypersensitivity to fluorouracil or any excipient
• Application to mucous membranes, lips, eyelids, inside of nostrils — mucosal absorption is much higher than cutaneous and severe reactions can result
• Biopsy-unconfirmed lesions — treating an undiagnosed lesion topically can mask the presentation of invasive cancer beneath
• Nodular or invasive BCC or invasive SCC — these require surgical management
• Kinderen — not indicated in paediatric skin conditions
• Immunosuppressed transplant patients — specialist dermatology decision; risk of delayed healing and systemic absorption
• Occlusive dressings — do not occlude unless specifically directed; occlusion dramatically increases absorption and severity of reaction

Geneesmiddelinteracties

• Systemic fluoropyrimidines (capecitabine, systemic 5-FU, tegafur) — do not use concurrently; severe toxicity risk
• Brivudine, sorivudine (antivirals) — inhibit DPD and can precipitate fatal systemic 5-FU toxicity even from topical application; ABSOLUTE avoid
• Other topical cytotoxic or immunomodulator agents (imiquimod, ingenol mebutate, diclofenac gel) — do not apply on the same area without specialist direction; sequential use is standard in some field-treatment protocols
• Topical corticosteroids — suppress the therapeutic inflammatory reaction; generally avoided during active treatment, may be used briefly for intolerable reactions under specialist direction
• Warfarine — IV 5-FU potentiates warfarin markedly; topical 5-FU has little systemic effect at normal use but monitor INR more closely if patient is on warfarin and using extensive topical 5-FU
• Fenytoïne — systemic 5-FU increases phenytoin levels; topical use rarely clinically significant

Sun Exposure Rules

Strict sun avoidance during treatment and for 1-2 months afterwards:

• Stay out of direct sunlight where possible during the treatment course. If outdoors, wear a broad-brimmed hat and fully cover the treated area.
• Do NOT use sunscreen directly on the inflamed/eroded treatment area during active reaction — sunscreen ingredients can sting severely and interfere with healing. Physical barrier (hat, clothing) instead.
• Once the skin has fully re-epithelialised and is healed (usually 6-8 weeks from treatment start), resume daily broad-spectrum SPF 50+ sunscreen — the treated skin is more sun-sensitive for 1-2 months and long-term sun avoidance is the cornerstone of preventing future actinic keratoses and skin cancer.
• No tanning beds, ever, in patients with a history of actinic keratoses or non-melanoma skin cancer.

Opslag en houdbaarheid

Store Flonida Cream at 15-25°C in the original tube, away from direct sunlight. Do NOT freeze. Replace cap tightly after use. Buiten bereik van kinderen en huisdieren houden — this is a cytotoxic drug and accidental ingestion or ocular contact requires urgent medical attention. Dispose of empty tubes per local cytotoxic-waste regulations (in many jurisdictions, return to a pharmacy — not domestic waste).

Veelgestelde vragen

Why does my skin look worse while using Flonida Cream?

The visible inflammatory reaction — redness, burning, erosion, crusting, weeping — IS the therapeutic mechanism. 5-FU is destroying dysplastic cells, and the immune clearance of the debris produces the inflammation. Patients who do not get a good reaction usually do not get a good clinical result. Stopping early because “it looks bad” is the most common reason for treatment failure. Your dermatologist will guide you on how intense a reaction to aim for and when to stop.

Can I use Flonida Cream on a spot I think might be skin cancer, without a biopsy?

No. Treating an undiagnosed lesion with topical 5-FU can flatten and partially clear an invasive cancer enough to mask its appearance while deeper disease progresses unchecked. All suspected skin cancer lesions need a biopsy and histological diagnosis before treatment — topical 5-FU is not appropriate for nodular BCC, invasive SCC, melanoma, or any lesion of uncertain diagnosis.

What is DPD deficiency and why does it matter for a topical cream?

Dihydropyrimidine dehydrogenase (DPD) is the enzyme that detoxifies 5-FU systemically. About 3-5% of people have partial deficiency; 0.2% have complete deficiency. In deficient patients, even the small amount of 5-FU absorbed from topical application can accumulate to toxic levels, producing severe mucositis, diarrhoea, bone-marrow failure and neurotoxicity. A family history of severe reactions to any fluoropyrimidine drug (capecitabine, systemic 5-FU, tegafur) is a red flag — screen before starting topical 5-FU. If in doubt, discuss with your dermatologist or oncologist.

Can I use makeup or sunscreen during treatment?

No cosmetics on the treated area during active treatment — they can cake into eroded skin, increase irritation, and inhibit healing. No sunscreen directly on the treatment area either; use physical sun protection (hat, long sleeves, umbrella) instead. Once healing is complete (6-8 weeks), restart daily broad-spectrum SPF 50+ sunscreen as long-term prevention.

Wat als ik een dosis vergeet?

Apply the next dose at the regularly scheduled time. Do not double up. Missing an occasional dose does not compromise the overall course meaningfully.

Is pregnancy really an absolute contraindication — it is only a skin cream?

Yes, absolutely. Enough 5-FU is absorbed from topical application to be teratogenic in animal studies, and there are case reports of fetal malformations after exposure in pregnancy. 5-FU is assigned Pregnancy Category X — the highest risk category, meaning the risk in pregnancy outweighs any possible benefit. Effective contraception is mandatory during and for at least 3 months after treatment. If you become pregnant during treatment, stop immediately and contact your doctor.

Can someone else touch my treated skin?

Avoid skin-to-skin contact of the treated area with other people — particularly children and pregnant women — until you have washed the treatment area and your hands. Wash your hands after every application. The residue on clothing or bedding is not a meaningful exposure risk to others.

What are the alternatives to Flonida Cream?

For actinic keratoses: cryotherapy (liquid nitrogen), imiquimod cream, diclofenac 3% gel, photodynamic therapy (PDT), ingenol mebutate. For superficial BCC: imiquimod, PDT, surgical excision, curettage and electrodessication, Mohs micrographic surgery. For invasive skin cancer: surgery (excision or Mohs), radiotherapy. Your dermatologist will recommend the best option based on lesion type, size, location, your skin type, other medical conditions, and treatment logistics.

Where can I order Flonida Cream online?

You can order Flonida Cream from MedsBase in standard pack sizes (10 g tube). Orders ship worldwide with discreet packaging. Topical fluorouracil is a specialist-supervised cytotoxic medicine in all jurisdictions; use only under dermatology supervision and after a biopsy-confirmed diagnosis.

Related Dermatology Products on MedsBase

• Tenovate Cream (clobetasol) — very-potent topical corticosteroid for inflammatory dermatoses (NOT for use on 5-FU treatment sites)
• A-Ret Gel (tretinoin) — topical retinoid used for photodamage, mild AKs, and adjunctive sun-damaged skin maintenance
• Retino-A Cream (tretinoin) — tretinoin cream for photodamaged skin
• T-Bact Ointment (mupirocin) — topical antibiotic if secondary infection develops during the erosive phase of 5-FU treatment

Handige lectuur: MedsBase klantbeoordelingen.

Gerelateerde alternatieven

Andere producten in Algemene gezondheid die klanten ook bekijken:

• Distaclor
• Oxyspas
• Licab
• Dulcoflex
• Cronotol

More options in Beauty & Skin Care

Gerangschikt op recente bestelvolumes van MedsBase — wat andere klanten in deze categorie kiezen.

Tretiheal Cream

US$7.00 – US$54.00Prijsbereik: US$7.00 tot US$54.00

Melalite Forte Cream

US$5.00 – US$27.00Prijsbereik: US$5.00 tot US$27.00

Retino A Cream

US$8.00 – US$42.00Prijsbereik: US$8.00 tot US$42.00

Kojiglo Gel

US$18.00 – US$87.00Prijsbereik: US$18.00 tot US$87.00